DrugBenefitTrends Members: Login | Register

Drug Benefit Trends

TOPIC CENTERS

Home Biologics Cardiovascular Care Comparative Effectiveness Research Conference Coverage Cost Savings Diabetes Management Disease Trends Drug Pipeline E-Prescribing Formulary Decisionmaking Generics Health Care Reform Infectious Disease Treatments Mail-Order Pharmacy Medicare Part D Mental Health Parity Neurological Management Oncology Treatments Patient Adherence Pharmacoeconomics Physician Compensation Psychiatric Management Respiratory Treatments Specialty Pharmacy Value-Based Benefit Design

MORE INFO

Article Archive About Us Subscribe to DBT


Home »

Drug Benefit Trends. Vol. 22 No. 2
Pages: 1  2  
Previous
Behavioral Health Matters 

Hyperparathyroidism Resulting From Lithium Treatment Remains Underrecognized

By Jay M. Pomerantz, MD | March 26, 2010

Dr Pomerantz practices psychiatry in Longmeadow, Mass, and is assistant clinical professor of psychiatry at Harvard Medical School in Boston.


Effects of Hyperparathyroidism
When a parathyroid gland enlarges and produces too much PTH, the blood calcium level becomes high, bones may lose calcium, and kidneys may excrete too much calcium. These changes may give rise to symptoms and signs such as polyuria, thirst, fractures, and kidney stones.

Neuropsychiatric symptoms associated with primary hyperparathyroidism include anxiety as well as cognitive and psychotic presentations. However, the most common presentation is depression with associated apathy.5 In a prospective study of 34 patients with hyperparathyroidism, Velasco and colleagues6 found that approximately one-third of participants had no psychiatric symptoms, one-third had affective symptoms (with or without paranoia), and one-third had cognitive impairment. Affective symptoms were most common in patients with modest elevations in electrolyte levels, while cognitive deficits were more often related to higher calcium concentrations.

(MORE: Treatment-Resistant Depression: Strategies for Management)

Hypercalcemia. The severity of psychiatric symptoms in patients with hyperparathyroidism often correlates with the increase in serum calcium levels. Calcium performs a crucial role in nerve conduction. Consequently, it is no surprise to find out that some common symptoms of parathyroid hyperactivity and high calcium levels are related to the nervous system.

Other symptoms have to do with the muscular system, which uses changes in intracellular calcium concentration to initiate and transmit the command to contract muscle fibers. Improper regulation of calcium levels may result in muscle cramps and weakness. The heart is a muscle, and therefore its conduction system is also vulnerable, with possible shortening of the QT interval, rhythm disturbances, and even cardiac death.

The skeletal system not only functions as the reservoir of calcium for the body, but calcium phosphate(Drug information on calcium phosphate) is an essential ingredient of bone tissue. Consequently, a hyperactive parathyroid system contributes to osteoporosis and vulnerability to bone fractures.

When hypercalcemia is present, it is important not only to screen for hyperparathyroidism but also to rule out other possible underlying conditions, such as malignancy and drug-induced elevations in calcium levels.

Case Note
Already, early in the process of screening for elevated calcium levels in my many patients who are receiving lithium(Drug information on lithium), I have identified a patient with hypercalcemia and a markedly elevated PTH level, which may indicate hyperparathyroidism. She is a 50-year-old woman with schizoaffective disorder who has been receiving long-standing lithium therapy and is undergoing further evaluation by an endocrinologist. All of us are hopeful that her recent cognitive decline and mental apathy will prove to be reversible.

Pages: 1  2  
Previous
 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.

  • Oldest First
  • Newest First

by Perry Zuckerman | April 15, 2010 12:13 PM EDT

Excellent!  Thank you!

by Noel fernando | November 19, 2010 4:32 PM EST

Thanks for the interesting article. During my 40yrs of Psychiatric practice I have seen several cases of hperparathyroidism in people suffering from Affective disorders. Therefore I routinely check calcium and phosphate levels and screening for hyperparathyroidism. thanks once again for brining this to the attention Dr Noel fernando MD, FRCPsych,FRANZCP,DPM(Eng)

Related Articles

Novel Treatment Avenues for Bipolar Depression

Comorbidity in Bipolar Disorder

Treatment-Resistant Depression: Strategies for Management

Hyperparathyroidism Resulting From Lithium Treatment Remains Underrecognized





References
1. Awad SS, Miskulin J, Thompson N. Parathyroid adenomas versus four-gland hyperplasia as a cause of primary hyperparathyroidism in patients with prolonged lithium therapy. World J Surg. 2003;27:486-488.
2. Garfinkel PE, Ezrin C, Stancer HC. Hypothyroidism and hyperparathyroidism associated with lithium. Lancet. 1973;2:331-332.
3. Bendz H, Sjödin I, Toss G, Berglund K. Hyperparathyroidism and long-term lithium therapy—a cross-sectional study and the effect of lithium withdrawal. J Intern Med. 1996;240:357-365.
4. Szalat A, Mazeh H, Freund HR. Lithium-associated hyperparathyroidism: report of four cases and review of the literature. Eur J Endocrinol. 2009;160:317-323.
5. Watson LC, Marx CE. New onset of neuropsychiatric symptoms in the elderly: possible primary hyperparathyroidism. Psychosomatics. 2002;43:413-417.
6. Velasco PJ, Manshadi M, Breen K, Lippmann S. Psychiatric aspects of parathyroid disease. Psychosomatics. 1999;40:486-490.






CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy